All posts by: Michael Zand

About Michael Zand

Better lung cancer treatment? Immunotherapy drug Keytruda boosts effectiveness of chemotherapy in trial – Genetic Literacy Project

Continue reading

2018-04-26 NEWS

Genetic Literacy Project

Better lung cancer treatment? Immunotherapy drug Keytruda boosts effectiveness of chemotherapy in trial
Genetic Literacy Project
A widely used immunotherapy drug appears to be useful in a greater number of patients with lung cancer. The drug called Keytruda, or pembrolizumab, is already prescribed to a group of patients who have a type of malignancy called non-small cell lung
‘This is not experimental anymore’: How immunotherapy is being used for some lung cancer and melanoma patientsCBC.ca
New hope for stage 4 lung cancer patientsFoster’s Daily Democrat

all 3 news articles »

Continue reading

2018-04-26 NEWS

Wall Street Journal

The Million Dollar Cancer Treatment: Who Will Pay?
Wall Street Journal
In January, he got a drug called Neupogen to boost his white blood cells. And he has regular follow-ups to make sure he doesn’t have lasting neurological effects. “Already hit my total out-of-pocket of $5,000 for this year,” Mr. Fries said in March. He

Continue reading

2018-04-26 NEWS

WBUR

CRISPR Wizard Feng Zhang: The Making Of A Sunny Science Superstar
WBUR
“Feng is a one-in-a-generation scientist who sees connections that the rest of us have overlooked,” says Robert Desimone, director of the McGovern Institute for Brain Research at MIT. “And by seeing those new connections, he’s able to make these

Continue reading

2018-04-26 NEWS

Kỹ thuật CRISPR không tế bào giúp cá nhân hóa việc điều trị ung thư – Báo Khoa học và Phát triển (lời tuyên bố phát cho các báo)

Báo Khoa học và Phát triển (lời tuyên bố phát cho các báo)Kỹ thuật CRISPR không tế bào giúp cá nhân hóa việc điều trị ung thưBáo Khoa học và Phát triển (lời tuyên bố phát cho các báo)“Bạn có thể biết kết quả sau khi quá trình chỉnh sửa gen hoàn tất, nh… Continue reading

2018-04-26 NEWS

New York Times

‘Desperation Oncology’: When Patients Are Dying, Some Cancer Doctors Turn to Immunotherapy
New York Times
Dr. Oliver Sartor has a provocative question for patients who are running out of time. Most are dying of prostate cancer. They have tried every standard treatment, to no avail. New immunotherapy drugs, which can work miracles against a few types of